trial · primary record
PRT13722
Breast Cancer
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 242 |
| Primary completion | 2029-10-31 |
| Primary endpoint | Dose limiting toxicity of PRT13722 (Parts 1A and 2) |
| Registry ID | NCT07905001 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:33:37.095Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07905001
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.